The Notch ligands, Delta/Serrate/Lag-2 (DSL) proteins, mediate the Notch signaling pathway in a numerous developmental processes in multicellular organisms. Although the ligands induce the activation of the Notch receptor, the intracellular domain-deleted forms of the ligands cause dominant-negative phenotypes, implying that the intracellular domain is necessary for the Notch signal transduction. Here we examined the role of the intracellular domain of Xenopus Serrate (XSICD) in Xenopus embryos. X-Serrate-1 has the putative nuclear localization sequence (NLS) in downstream of the transmembrane domain. Biochemical analysis revealed that XSICD fragments are cleaved from the C-terminus side of X-Serrate-1. Fluorescence microscopic analysis showed that the nuclear localization of XSICD occurs in the neuroectoderm of the embryo injected with the full-length X-Serrate-1/GFP. Overexpression of XSICD showed the inhibitory effect on primary neurogenesis. However, a point mutation in the NLSs of XSICD inhibited the nuclear localization of XSICD, which caused the induction of a neurogenic phenotype. The animal cap assay revealed that X-Serrate-1 suppresses primary neurogenesis in neuralized animal cap, but X-Delta-1 does not. Moreover, XSICD could not activate the expression of the canonical Notch target gene, XESR-1 in contrast to the case of full-length X-Serrate-1. These results suggest that the combination of XSICD-mediated intracellular signaling and the extracellular domain of Notch ligands-mediated activation of Notch receptor is involved in the primary neurogenesis. Moreover, we propose a bi-directional signaling pathway mediated by X-Serrate-1 in Notch signaling.
Introduction
Cell -cell interactions modulate cell fate and pattern formation by influencing temporal and position-dependent differentiation in the development of invertebrates and vertebrates (Gurdon, 1992) . The interaction of LIN12/Notch family proteins is involved in lateral specification of cell fate (Greenwald, 1998; Artavanis-Tsakonas et al., 1999) . The product of Notch gene, encoding a single-pass transmembrane protein, functions as the signal receptor and mediates the mechanism termed lateral inhibition which allows an individual cell or a population of cells to be singled out from the surrounding cells in the development of the nervous system in Drosophila melanogaster (Artavanis-Tsakonas et al., 1995) .
The Notch signaling pathway appears to be substantially conserved in vertebrates and invertebrates (Weinmaster, 1997) . Indeed, the core members included CBF1/Suppressor of Hairless/Lag-1 (CSL) transcriptional cofactors and target genes such as the Hairy/Enhancer of Split family of basic helix -loop -helix transcriptional regulators are well conserved beyond species (Munn and Kopan, 2000) . In a current model, the mature Notch receptor is a heterodimer composed of amino-terminal 180 kDa and carboxy-terminal 120 kDa fragments which are generated via proteolytic cleavage of full-length Notch protein by a furin-like convertase (Shawber et al., 1996; Blaumueller et al., 1997; Logeat et al., 1998) . The Notch receptor activated by ligand molecules cause a conformational change, and is cleaved at the extracellular region near the transmembrane domain by Kuzbanian and TACE (TNF-› (tumor necrosis factor-›) converting enzyme) for its proteolysis of TNF-›, known as a disintegrin and metalloprotease domain (ADAM) family (Weinmaster, 1998; Hardy and Israel, 1999; Lieber et al., 2002) . Continuously, the intracellular domain of Notch receptor (NICD) is released after the processing at intramembrane cleavage site by gamma-secretase-like protease, probably Presenilin, and transported into the nucleus (Strooper et al., 1999; Struhl and Greenwald, 1999) . In the nucleus, the NICD fragment binds directly to the CSL protein, and converts it from a transcriptional repressor to a transcriptional activator (Weinmaster, 2000) . In addition, several other important components of the Notch -enhancer complex, such as Mastermind (MAM) and SKIP (Ski-interacting protein), have been identified genetically and biochemically. MAM is a nuclear protein which interacts directly with the NICD-CBF1 complex and stabilizes its binding to DNA in vitro (Helms et al., 1999; Petcherski and Kimble, 2000; Kitagawa et al., 2001) . SKIP can also associate with the NICD -CBF1 complex replaced with histone deacetylases and CtBP, SMRT, or CIR corepressors (Kao et al., 1998; Hsieh et al., 1999; Morel et al., 2001 ) and activate CBF1-repressed promoters (Zhou et al., 2000) . Thus, many proteins that act in Notch signal-receiving cells have been identified.
Although Delta and Serrate (Jagged) are single-pass transmembrane proteins and act as Notch ligand molecules in Notch signal-releasing cells, the significance of those is not yet fully understood. The Notch ligand molecules contain the DSL (Delta/Serrate/Lag-2) domain, which can interact with the epidermal growth factor (EGF) motif of Notch receptors in the extracellular region (Rebay et al., 1991; , and activate Notch signaling. Mutations that disrupt the function of Delta or Serrate affect the normal development in several species. For example, a mis-sense mutation in EGF motif of Delta generates a large excess of hair cells in the inner ear of zebrafish (Riley et al., 1999) . In the homozygous mutant lacking the DSL domain of mouse Jagged2, histological defects occur in limb, craniofacial, and thymic development (Jiang et al., 1998) . In Drosophila, DSL ligands lacking the transmembrane and intracellular domain of the wild-type protein induce the neuronal hyperplasia during embryonic neurogenesis, and perturb eye and wing formation by antagonizing the Notch function (Hukriede et al., 1997; Sun and Artavanis-Tsakonas, 1997) . Moreover, the intracellular domain-deleted forms of Delta and Serrate result in neurogenic phenotypes (Chitnis et al., 1995; Sun and Artavanis-Tsakonas, 1996; Kiyota et al., 2001) . These most mutants are defined as dominant-negative phenotypes. Delta is detected on cell surfaces, but also in intracellular vesicles during some developmental stages (Parks et al., 1995; Huppert et al., 1997) . Recent studies have indicated that the cis-endocytosis of the ligand molecule is required for the activation of Notch signaling (Klueg and Muskavitch, 1999; Parks et al., 2000) . The intracellular domain-deleted form of Delta may not cis-endocytose as discussed by Parks et al. (2000) , and can trigger cleavage in the extracellular domain of Notch2, but not in the intracellular domain of Notch2 (Shimizu et al., 2002) . Furthermore, the ubiquitylation of the intracellular domain of Delta is involved in the cell surface level and the cis-endocytosis of Delta molecule (Deblandre et al., 2001; Itoh et al., 2003) . These findings suggest that the intracellular domain of Notch ligands may have some active role for modification of the signal transduction in the Notch pathway.
Here we show that the intracellular domain of Xenopus Serrate (XSICD) is cleaved from the full-length X-Serrate-1 and accumulated in the nucleus. Furthermore, we provide evidence that XSICD has the inhibitory effect on primary neurogenesis, but a point mutation in the nuclear localization sequence (NLS) of XSICD inhibits the nuclear localization of XSICD, which results in the induction of a neurogenic phenotype. Taken together, we propose a bidirectional signaling pathway mediated by the Serrate molecule in Notch signaling.
Results
2.1. The prospective nuclear localization sequence is conserved in the intracellular domain of vertebrate Serrate/Jagged family Earlier work has shown that the intracellular deletion form of the Notch ligand induces a dominant-negative phenotype (Chitnis et al., 1995; Sun and ArtavanisTsakonas, 1996; Kiyota et al., 2001) . As is well known, overexpression of wild-type ligand suppresses primary neurogenesis, which is marked by the gene expression of N-tubulin, a neuron-specific type-II b-tubulin gene (Oschwald et al., 1991) (Fig. 1A,B) , whereas dominantnegative forms of Notch ligands induce an overproduction of primary neurons (Fig. 1C,D) . To determine why the intracellular deletion form of the Notch ligand shows the dominant-negative phenotype, we examined the role of the intracellular domain of the Notch ligand. As shown in the alignment of amino acid sequences among several Notch ligands ( Fig. 2A) , the putative NLSs were found in downstream of the transmembrane domain in the Serrate (Jagged) family and some of Delta family in vertebrates and Drosophila Delta (Sun and Artavanis-Tsakonas, 1996) . Actually, X-Delta-1, C-Delta-1, mouse Delta-like (Dll) 1, and human Dll1 contain NLSs at amino acids 687 -690, 694 -697, 688-691, and 689 -692 of the C-terminal side, respectively, but not Drosophila Serrate, mouse Dll3, 4, and human Dll3, 4. Therefore, we made a variety of constructs for X-Delta-1 and Xenopus Serrate-1 (X-Serrate-1) to investigate the role of the intracellular domain of the Notch ligands (Fig. 2B ).
The intracellular domain of X-Serrate-1 is localized in the nucleus
Previous report showed that the soluble form of intracellular domain of Drosophila Delta is localized in the nucleus of photoreceptor precursors and core cells in third instar eye discs (Sun and Artavanis-Tsakonas, 1996) . To examine the intracellular localization of several Notch ligands, synthetic RNAs of constructs fused in frame with Green Fluorescent Protein (GFP) were injected into one blastomere of a two-cell stage embryo. The tissues expressing GFP fluorescence were isolated at gastrula (stage 9) or neurula (stage 14) stages, and treated with 4 0 6,-diamino-2-phenyl-indole (DAPI) to stain the nucleus. As shown in Fig. 3A , XDICDGFP (the intracellular domain of X-Delta-1 fused with GFP) and XSICDGFP were strongly localized in the nucleus, but not MycGFP and XSICDmtGFP, in which 1092nd arginine in the putative NLS of X-Serrate-1 is replaced with a threonine causing mutation of NLS (Kalderon et al., 1984) . As compared with XSICDGFP, the major fluorescence of XSICDmtGFP was clearly in the cytoplasm. In addition, biochemical analysis revealed that amount of XSICDmtGFP proteins was the same as that of XSICDGFP (data not shown). Therefore, these results suggest that the nuclear localization of XSICDmt is decreased because of the mutation for the putative NLS of XSICD, but not the degradation of XSICDmt. When the full-length Notch ligand was injected, XDlGFP (X-Delta-1 fused with GFP) was found on the plasma membrane and in the cytoplasm as cis-endocytosed granules in gastrula stage embryos (Fig. 3B) , as is also seen in Drosophila Delta (Klueg and Muskavitch, 1999; Parks et al., 2000) . In contrast, XSerGFP (X-Serrate-1 fused with GFP) and XSermtGFP (X-Serrate-1mt fused with GFP; X-Serrate-1mt is mutated in the NLS as same as XSICDmt) were detected only on the plasma membrane (Fig. 3B ). As shown in Fig. 3C , the distribution of XDlGFP and XSermtGFP at the neurula stage was the same as that in the gastrula stage. Only in the embryo injected with XSerGFP, however, nuclear localization of GFP was found in part of neuroectoderm. These results suggest that the intracellular domain of X-Serrate-1 may be cleaved and localized in the nucleus. 
The intracellular domain of X-Serrate-1 is cleaved at the neurula stage
Next, we examined whether X-Serrate-1 is proteolytically cleaved. To investigate this hypothesis, a combination of microinjection of synthetic RNAs and immunoprecipitation was used. We first performed immunoprecipitation with the anti-myc antibody (Fig. 4A,B ). The immunoblot with the anti-GFP antibody showed that MycGFP as a positive control and X-Serrate-1-MycGFP (XSerMycGFP) are detected at 45 and 185 kDa, respectively (Fig. 4A , asterisk and opened arrowhead). However, the immunoblot with the anti-myc antibody showed that the 120 kDa protein is also detected in addition to 185 kDa of XSerMycGFP (Fig. 4B , black arrow). The 120 kDa band was not detected in the immunoblot with the anti-GFP antibody (Fig. 4A) . Therefore, this band is including the N-terminus side of XSerMycGFP without the GFP-tagged C-terminus.
To confirm the cleavage of the C-terminus from XSerMycGFP, we performed immunoprecipitation with the anti-GFP antibody (Fig. 4C,D) . The immunoblot with the anti-myc antibody showed that the 45 kDa protein of MycGFP and the 185 kDa protein of XSerMycGFP are detected in the same pattern as in the immunoblot with the anti-GFP antibody after immunoprecipitation with the antimyc antibody (Fig. 4A,C) . However, the immunoblot with the anti-GFP antibody showed that the 44 kDa protein of XSerMycGFP, which is not detected in the immunoblot with the anti-myc antibody in Fig. 4C , is barely detected in addition to the 185 kDa protein (Fig. 4D) . To clear the cleavage of the C-terminus from X-Serrate-1, we examined it with another constructs, XSICDcMyc and XSercMyc (XSICD and X-Serrate-1 fused with myc-tag in the C-terminus side). Immunoprecipitation and immunoblot with the anti-myc antibody showed that the 40 kDa protein is clearly detected in addition to the 180 kDa protein in the sample injected with XSercMyc (Fig. 4E, black arrow) . These results indicate that the intracellular domain of X-Serrate-1 is proteolytically cleaved from the C-terminus side of the full-length form.
X-Delta-1 is also proteolysised on Xenopus neuroectoderm
A recent study showed that Kuzbanian is involved in the processing of Drosophila Notch, and also Delta in the extracellular region (Qi et al., 1999; Lieber et al., 2002) . Therefore, we also examined whether X-Delta-1 is processed proteolytically. A single band of full-length X-Delta-1-MycGFP (XDlMycGFP) was detected with a size of 135 kDa in the immunoblot with the anti-GFP or anti-myc antibody after immunoprecipitation with the anti-myc or anti-GFP antibody, respectively (Fig. 4A,C , black arrowhead). However, the immunoblot with the antimyc antibody after immunoprecipitation with the anti-myc antibody showed that the 88 kDa and slight 80 kDa bands are also detected in addition to 135 kDa of XDlMycGFP (Fig. 4B, gray arrowhead and asterisk) . The 88 and 80 kDa bands were not detected in the immunoblot with the anti-GFP antibody (Fig. 4A) . Therefore, these bands are including the N-terminus side of XDlMycGFP without the GFP-tagged C-terminus. Furthermore, the immunoblot with the anti-GFP antibody after immunoprecipitation with the anti-GFP antibody showed that the 47 kDa protein of XDlMycGFP is barely detected in addition to the 135 kDa protein (Fig. 4D) . To clear the cleavage of the C-terminus from X-Delta-1, we examined it with XDICDcMyc and XDlcMyc as same as the case of X-Serrate-1. Immunoprecipitation and immunoblot with the anti-myc antibody showed that the 40, 42 and 45 kDa proteins are detected in addition to the 115 kDa protein in the sample injection with XDlcMyc (Fig. 4E, gray arrowhead and asterisk) . Especially, 40 and 42 kDa proteins were the same size as XDICDcMyc. These results indicate that X-Delta-1 is also processed proteolytically on Xenopus neuroectoderm.
2.5. The intracellular domain of X-Serrate-1 can suppress primary neurogenesis
As described above, the intracellular deletion form of the Notch ligand induces a neurogenic phenotype (Fig. 1C,D) . Then, we examined whether the intracellular domain of the Notch ligand affects primary neurogenesis. Synthetic RNAs of several constructs were injected into one blastomere of a two-cell stage embryo, and primary neurogenesis was analyzed using the expression of N-tubulin as a neural marker gene at the neurula stage (Fig. 5A-D, Table 1 ). As already shown in Fig. 3A , the intracellular domains of the Notch ligands were localized in the nuclei. However, XDICD had no effect on primary neurogenesis, and could not rescue the neurogenic phenotype induced by dominant-negative forms of the Notch ligands (Fig. 5A) . In contrast, surprisingly, XSICD could inhibit primary neurogenesis on the injected side, and suppressed X-Delta-1
Stu or X-Serrate-1 Eco -induced overproduction of primary neurons (Fig. 5B) . The neuronal suppression of XSICD was completely lost by inducing a single mutation into the NLS region of the molecule. Furthermore, the NLS-mutated form of XSICD (XSICDmt) induced the neurogenic phenotype, in many cases (Fig. 5C , Table 1 ). In addition, XSICDmt did not have an inhibitory effect on the neurogenic phenotype induced by X-Delta-1 Stu or X-Serrate-1
Eco as XSICD (Fig. 5C ). The similar results were obtained in the case of injection with the NLS-mutated form of X-Serrate-1 (Fig. 5D ). These evidences suggest that the nuclear localization of XSICD is necessary and sufficient for the regulation of primary neurogenesis.
X-Serrate-1 inhibits the induction of N-tubulin expression in neuralized animal cap
The results described above showed that XSICD causes an inhibitory effect on primary neurogenesis, but XDICD does not. If the full-length X-Serrate-1 essentially has the intracellular-dependent signaling as well as Serrate-Notch signaling by the binding of the DSL domain of X-Serrate-1 to Notch receptor in the extracellular region, X-Serrate-1 itself may have an effect on the expression of N-tubulin, different from the case of X-Delta-1. To investigate whether X-Serrate-1 has different activities from X-Delta-1, the effects of both ligands were examined with animal cap neuralized with a truncated BMP (bone morphogenetic protein) receptor, tBR (Graff et al., 1994) , which can directly induce expression of NCAM, the pan-neural marker, without expression of the mesodermal marker genes (Hawley et al., 1995; Xu et al., 1995;  Fig. 6A ). We ascertained that injection of tBR alone also caused induction of N-tubulin expression with the animal cap assay and quantitative reverse transcript-polymerase chain reaction (RT-PCR) (Fig. 6A ). In addition, it did not induce a marker of paraxial mesoderm, MyoD, and a marker of ventral mesoderm, alpha-globin (Hopwood et al., 1989; Banville and Williams, 1985) . Under this condition, in situ hybridization was performed in neuralized animal cap to examined expression of N-tubulin. Though injection of FITC alone did not induce expression of N-tubulin, tBR with FITC did it in the FITC-positive cells (Fig. 6C,D , black asterisk). X-Delta-1 has no effect on expression of Ntubulin in the FITC-negative (X-Delta-1-positive) cells, in the same case as tBR alone. Surprisingly, the induction of N-tubulin-expression was inhibited with a mixture of tBR and X-Serrate-1 RNA in the FITC-positive cells (Fig. 6F , black asterisk). These results suggest that X-Serrate-1 is thought to have a different activity from X-Delta-1 in the primary neurogenesis.
The intracellular domain of X-Serrate-1 does not activate the expression of Notch target gene, XESR-1
We previously showed that both X-Delta-1 and X-Serrate-1 activate the expression of XESR-1 (Xenopus Enhancer of split-related gene-1; Wettstein et al., 1997) , the target gene on the canonical Notch-mediated signaling pathway in animal cap (Kiyota and Kinoshita, 2002) . The results described above, however, showed that X-Serrate-1 play a different role from that of X-Delta-1 in neuralized animal cap. In addition, XSICD causes an inhibitory effect on primary neurogenesis. To investigate whether the effect depends on the canonical Notch-mediated signaling pathway or not, activation of XESR-1 was examined. As described previously, we utilized the animal cap assay and RT-PCR for this analysis (Kiyota and Kinoshita, 2002) . As shown in Fig. 7 , both full-length X-Serrate-1 and NICD, constitutively activated form of X-Notch-1 (Chitnis et al., 1995) , caused strong induction of XESR-1 expression. However, XSICD showed an inductive capacity as low as the background level. These results indicate that XSICD can suppress the primary neurogenesis but not promote the activation of XESR-1, which is the canonical Notch target gene.
Discussion
We have shown that XSICD plays a novel role in the regulation of primary neurogenesis in the Xenopus laevis embryo. Generally, it is thought that the DSL domain of the Notch ligand binds to the EGF-like repeats in the extracellular region of the Notch receptor in order to activate the Notch signaling in neighboring cells (Artavanis-Tsakonas et al., 1995; Weinmaster, 1997 Weinmaster, , 1998 Weinmaster, , 2000 . Here we showed that X-Delta-1 is cis-endocytosed into self-expressing cells in the primary neurogenesis. The cis-endocytosis of X-Delta-1 is the same as that of Drosophila Delta during the developmental process of eye and wing (Parks et al., 2000) , perhaps for activation of the Notch receptor by promoting the processing of NICD, which in turn activates the target gene with CSL protein in the neighboring cell. Consequently, the neighboring cell is suppressed to differentiate into a neural cell by transcriptional regulation of the Notch-target gene. X-Delta-1
Stu may prevent X-Delta-1 from cis-endocytosing as discussed in the case of Drosophila (Parks et al., 2000) , or inhibit Notch signal transduction by the cell-autonomous association of XDelta-1
Stu and Notch receptor in the cytoplasm as occurred in COS-7L cells (Sakamoto et al., 2001 ). On the other hand, it is revealed that X-Delta-1 is proteolytically processed on Xenopus neuroectoderm. However, XDlGFP was mainly found in the cytoplasm as cis-endocytosed granules, but not in the nucleus. In addition, the amount of XDICD cleaved from XDlMycGFP was little. Recent studies have indicated that ubiquitylation of the intracellular domain of Delta is involved in the decrease on the cell surface level and the cisendocytosis of Delta molecule (Deblandre et al., 2001; Itoh et al., 2003) . Therefore, XDICD cleaved from the Cterminus side of full-length X-Delta-1 may be proteolytically degraded after the ubiquitylation. In Fig. 4E , two bands, 40 and 42 kDa proteins of XDICDcMyc, or XDlcMyc were detected with immunoprecipitation and immunoblot with the anti-myc antibody. Moreover, much smaller bands were also detected. These may possibly occur with the proteolytical degradation. Additionally, although the 45 kDa band is apparently larger than that of XDICD, it may be the membrane-tethered protein cleaved in the extracellular region as the same case as Drosophila Delta (Qi et al., 1999) . Although XDICDGFP is localized in the nucleus, XDICD does not show any activity on Xenopus primary neurogenesis. Therefore, the NLS sequence in XDICD, which has a role to translocate in the nucleus, may indicate nothing more than the clustering of charged residues, as reported in the intracellular domain of Drosophila Delta (Sun and Artavanis-Tsakonas, 1996) .
In contrast, the GFP-tracing and immunoprecipitation experiments demonstrated that the intracellular domain of XSerrate-1 is cleaved and translocated in the nucleus to regulate the differentiation of primary neurons. The NLS mutant of XSICD (XSICDmt) was prevented from localizing in the nucleus. Surprisingly, XSICDmt lost the inhibitory effect on primary neurogenesis and increased the number of primary neurons in many cases. These evidences indicate that the translocation of XSICD in the nucleus is essential for regulation of primary neurogenesis. The animal cap assay revealed that X-Serrate-1 suppresses primary neurogenesis in neuralized animal cap, but X-Delta-1 does not. If the inhibitory effect is via the canonical Notch signaling, X-Delta-1 should also suppress primary neurogenesis in the same system, because X-Delta-1 could activate the expression of XESR-1 as same as X-Serrate-1 in animal cap (Kiyota and Kinoshita, 2002) . Therefore, these findings suggest that X-Serrate-1 is involved in a specific signal transduction pathway on neural determination distinguishable from the canonical Notch signaling in this system. The hypothetical action of X-Serrate-1 is summarized in Fig. 8 . There are two pathways for the action of X-Serrate-1. One is that on the canonical Notch-mediated signaling pathway by binding the DSL domain of X-Serrate-1to EGF motif of Notch receptor (Fig. 8A) , because X-Serrate-1 induces the activation of the Notch target gene, XESR-1. The other is that by XSICD itself (Fig. 8B) . In the X-Serrate-1-expressing cell, XSICD is cleaved by an unknown protease (X) and translocated in the nucleus. XSICD could not activate the expression of XESR-1 in contrast to the case of full-length XSerrate-1. The inhibitory effect of XSICD may not be related to the canonical Notch-mediated signaling pathway. Therefore, XSICD causes the inhibitory effect on primary neurogenesis by two putative pathways: XSICD may suppress directly the expression of proneuronal gene; XSICD may activate some genes that repress the neuronal differentiation. In the cytoplasmic pathway, XSICD may associate with some Notch-related factors, because the neurogenic phenotype was induced by XSICDmt. The NLS mutant of X-Serrate-1 (XSermt) also induced the neurogenic phenotype similar to XSICDmt, which suggests that the nuclear translocation of XSICD is important. Because the effect of XSermt is lower than that of XSICDmt on primary neurogenesis and XSermtGFP were detected only on the plasma membrane, therefore XSermt probably might not be proteolytically cleaved to produce the XSICDmt fragment because the fragment is not translocated in the nucleus. In any case, XSICD by itself can show an inhibitory effect on primary neurogenesis, which is completely different from the case of XDICD. Although it is remained that whether XSICD has an inhibitory effect cell-autonomously and other molecule (e.g. Notch protein in the neighboring cell) is necessary for the generation of XSICD, we propose a bi-directional pathway mediated by the Serrate molecule in Notch signaling.
We previously have shown that X-Serrate-1 and X-Delta-1 play complementary roles, but independently in Xenopus primary neurogenesis (Kiyota et al., 2001) . It has recently been revealed that the cysteine-rich region of X-Serrate-1, which is a Serrate-specific motif, is required for the activation of Notch signaling (Kiyota and Kinoshita, 2002) . In addition, the secreted form of Serrate suppresses the expression of the Notch target gene, but that of Delta does not in the eye disc of Drosophila (Sun and Artavanis-Tsakonas, 1997) . These findings suggest that Serrate is involved in a specific signal transduction pathway distinguishable from that of Delta. In addition, Delta and Serrate are complementarily expressed in the central nervous system of Xenopus and Chick (Myat et al., 1996; Kiyota et al., 2001) . Therefore, it is likely that the combination of cis-endocytosis of X-Delta-1 to activate the canonical Notch-mediated signaling pathway and the translocation of XSICD in the nucleus is involved in the primary neurogenesis. Since XSICD does not have any specific motif, its functional domain and physiological role remain to be determined in the future.
Experimental procedures

DNA constructs
Each gene was inserted into the vector pCS2
þ (Turner and Weintraub, 1994) . X-Delta-1, X-Delta-1
Stu , X-Serrate-1 and X-Serrate-1
Eco have been described previously (Kiyota et al., 2001) . MycGFP RNA was made from pCS2 þ mtUGP (gift from Dr M. Klymkowsky). To produce the XDICD construct, the Bam HI/Eco RV fragment of X-Delta-1 was replaced with the PCR fragment synthesized using primers DelICDup (5 0 -TAGGGATCCCTGTATGAGGGTTA GAGTGCA-3 0 ) (upstream) and T3 (5 0 -CAGCTAT GACCTTGATTACGCCAAGCTCGA-3 0 ) (downstream). To produce the XDICDGFP construct, the PCR fragment synthesized using primers DelICDup and DelGFP-D (5 0 -CCGCGAATTCTAGACACCTCTGTTGCAATG-3 0 ) (downstream) was inserted into Bam HI/Xba I sites in pCS2 þ mtUGP. To produce the XDlGFP construct, XDICDGFP was digested with Stu I and Not I, and ligated into the same sites in X-Delta-1. To produce the XSerGFP construct, the Bst EII/Xba I fragment of X-Serrate-1 was replaced with the PCR fragment synthesized using primers T3 (upstream) and SerGFP-D (5 0 -CCCGCATCTAGATAC GATGTATTCCATCCG-3 0 ) (downstream), and the Xba I/ Not I fragment digested from pCS2 þ mtUGP was ligated into the same sites.
To produce the XSermt or XSermtGFP construct, the Bst EII/Xba I fragment of X-Serrate-1 or XSerGFP was replaced with the PCR fragment synthesized using primers Sermtup (5 0 -ATTCCGCGGTAACCGCTTTT TATTGGT GCATCCGGAAAACTAGAA-3 0 ) (upstream) and T3 or SerGFP-D (downstream), respectively. To produce the XSICD or XSICDGFP construct, the PCR fragment synthesized using primers SerICDup (5 0 -AGCG GATCCGC-TATGTATTGGTGCATCCG-3 0 ) (upstream) and T7 (5 0 -TAAGTTGGGTAACGCCAGGGTTTTCC CAGT-3 0 ) or SerGFP-D (downstream) was inserted into Bam HI/Xba I sites in pCS2 þ or pCS2 þ mtUGP, respectively. The
XSICDmt or XSICDmtGFP construct was produced in the same way as XSICD or XSICDGFP, except using an upstream primer SICDmtUp (5 0 -AGCG GATCCGCTATG-TATTGGTGCATCCGGAAAACTAGAA-3 0 ) instead of SerICDup. To produce the XDlMycGFP or XSerMycGFP construct, the Cla I/Xba I fragment of pCS2 þ mtUGP was ligated into the same sites in the pBK-CMV (Stratagene), which is called 6myc/pBK-CMV, and the Dra I/Sca I fragment was ligated in frame into the Sma I or Stu I site in XDlGFP or XSerGFP, respectively. To produce the XDlcMyc, XDICDcMyc, XSercMyc or XSICDcMyc construct, the Dra I/Sal I fragment of 6myc/pBK-CMV was ligated into Sma I/Sal I sites in the pBluescript SKII(þ ) vector (Stratagene), and the Xba I fragment was ligated in flame into the C-terminus end of cording region. After being digested with Not I for all constructs, capped mRNA was made using a mCAP RNA synthesis kit (Gibco BRL) according to the manufacturer's instructions. NICD and tBR RNA was made from NICD/pCS2 þ and pSP64T-tBMPR clone, respectively (gifts from Dr C. Kintner and Dr D. A. Melton; Chitnis et al., 1995; Graff et al., 1994) .
Embryo treatment
Embryo manipulations, microinjection, b-galactosidase staining and whole-mount in situ hybridization were performed as described previously (Kiyota et al., 2001) . For observation of GFP localization, synthetic RNA of each GFPfused construct was injected into one blastomere of a two-cell stage embryo. The tissue expressing GFP fluorescence was isolated with manual dissection at the gastrula or neurula stage, and fixed with 4% paraformaldehyde in phosphatebuffered saline (PBS) for 1 h at room temperature. After four washes with PBS with 0.1% Tween-20 (PBST), the tissue was stained with DAPI (1 mg/ml in PBS) for 30 min at room temperature. After four washes with PBST, the tissue was mounted on a glass slide with 20% glycerol in PBS. Images were taken with a Leica TCS 4D microscope and PDMC Ie camera (Polaroid) using the fluorescein or ultraviolet filter.
Immunoprecipitation
The embryo was injected into the bilateral side of a twocell stage embryo with synthetic RNA of each GFP or mycfused construct, and sampled at the neurula stage. Protein extraction and immunoprecipitation were performed using Protein A/G PLUS-Agarose in combination with anti-myc mouse monoclonal antibody c-Myc (9E10), or anti-GFP rabbit polyclonal antibody GFP (FL) according to the manufacturer's instructions (Santa Cruz Biotechnology). For immunodetection of precipitates, we used 9E10 or anti-GFP mouse monoclonal antibody GFP (B-2) (Santa Cruz Biotechnology) as primary antibody, and Alexa Fluorw680-conjugated anti-mouse IgG(H þ L) antibody (Molecular Probes) as secondary antibody. The bands were detected by Odyssey ODY-9201-S (LICOR).
Animal cap assay and quantitative RT-PCR analysis
tBR RNA alone (2 ng), or a mixture of X-Delta-1 RNA (1 ng) with tBR or X-Serrate-1 RNA (1 ng) with tBR was injected into each blastomere of the 2-cell embryo according to the combination indicated in Fig. 6 . To distinguish the side injected with tBR RNA alone, dextran, fluorescein (Molecular Probes) was used as a tracer. Animal cap was excised from the blastula stage (stage 8), cultured until the normal embryo reached stage 14 or 25. Quantitative RT-PCR for XESR-1 and Histone H4 expression was performed as described previously (Kiyota and Kinoshita, 2002 
